El tratamiento intralesional de Leishmaniasis cutánea es seguro frente al riesgo de complicaciones mucosas?

Limachi-Choque, Jhonny Wilson; Rojas-Cabrera, Ernesto; Verduguez-Orellana, Aleida; Eid-Rodríguez, Daniel.
Gac. méd. boliv ; 43(1): 18-22, ago. 2020. ilus
Artigo em Espanhol | LILACS | ID: biblio-1124814

Documentos relacionados

  1. [Cutaneous leishmaniasis].
  2. Large scale systemic control short-circuits pathogen transmission by interrupting the sand rat (Psammomys obesus)-to-sand fly (Phlebotomus papatasi) Leishmania major transmission cycle.
  3. Multi-sensorial perceptions of risk: the aesthetics behind (muco)cutaneous leishmaniasis-related stigma in Ecuador.
  4. Evidence supporting the enhanced efficacy of pentavalent antimonials with adjuvant therapy for cutaneous leishmaniasis: a systematic review and meta-analysis.
  5. Limited Cutaneous Leishmaniasis as Ulcerated Verrucous Plaque on Leg, Tucson, Arizona, USA<sup>1</sup>.
  6. Simple and promising paper-based electrochemical platform for serological detection of American tegumentary leishmaniasis.
  7. Bases for a treatment of cutaneous leishmaniasis with moderate hyperthermia.
  8. Cutaneous leishmaniosis due to Leishmania mexicana in a cat treated with cryotherapy.
  9. [Leishmaniose].
  10. Efficacy of Systemic Treatment for Leishmania tropica Cutaneous Leishmaniasis.